Optochemical control of slow-wave sleep in the nucleus accumbens of male mice by a photoactivatable allosteric modulator of adenosine A 2A receptors.
Koustav RoyXu-Zhao ZhouRintaro OtaniPing-Chuan YuanShuji IokaKaspar E VogtTamae KondoNouran H T FaragHaruto IjiriZhao-Fa WuYouhei ChitoseMao AmezawaDavid S UygunYoan CherasseHiroshi NagaseYulong LiMasashi YanagisawaManabu AbeRadhika BasheerYi-Qun WangTsuyoshi SaitohMichael LazarusPublished in: Nature communications (2024)
Optochemistry, an emerging pharmacologic approach in which light is used to selectively activate or deactivate molecules, has the potential to alleviate symptoms, cure diseases, and improve quality of life while preventing uncontrolled drug effects. The development of in-vivo applications for optochemistry to render brain cells photoresponsive without relying on genetic engineering has been progressing slowly. The nucleus accumbens (NAc) is a region for the regulation of slow-wave sleep (SWS) through the integration of motivational stimuli. Adenosine emerges as a promising candidate molecule for activating indirect pathway neurons of the NAc expressing adenosine A 2A receptors (A 2A Rs) to induce SWS. Here, we developed a brain-permeable positive allosteric modulator of A 2A Rs (A 2A R PAM) that can be rapidly photoactivated with visible light (λ > 400 nm) and used it optoallosterically to induce SWS in the NAc of freely behaving male mice by increasing the activity of extracellular adenosine derived from astrocytic and neuronal activity.
Keyphrases
- transcription factor
- protein kinase
- visible light
- sleep quality
- small molecule
- resting state
- white matter
- induced apoptosis
- functional connectivity
- signaling pathway
- spinal cord
- photodynamic therapy
- genome wide
- genome wide analysis
- depressive symptoms
- cell proliferation
- risk assessment
- cell death
- brain injury
- pi k akt